<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO> WSJ870720-0025 </DOCNO><HL> Business Brief:Genex Corp.</HL><DD> 07/20/87</DD><SO> WALL STREET JOURNAL (J)</SO><IN> GNEX </IN><TEXT>   Genex Corp. said shareholders at the annual meeting approved increasing authorized shares to 50 million from 21 million and reincorporating the company in Delaware; it now is incorporated in Maryland. The Gaithersburg, Md., genetic and biochemical engineering concern said the approval permits it to proceed with a rights offering of convertible preferred stock, which is expected to raise about $8 million. Genex said the offering is the first in a series of steps designed to provide the funding necessary to transform the company into a &quot;highly focused, applied biotechnology company that designs and manufactures specialized proteins and protein products for critical applications.&quot; </TEXT></DOC>